Innoviva, Inc.
INVA
$22.41
$0.090.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 174.85M | 144.42M | 128.97M | 128.72M | 116.98M |
| Total Other Revenue | 236.48M | 244.10M | 241.26M | 241.13M | 241.73M |
| Total Revenue | 411.33M | 388.52M | 370.23M | 369.84M | 358.71M |
| Cost of Revenue | 91.06M | 63.95M | 39.96M | 37.84M | 33.37M |
| Gross Profit | 320.27M | 324.57M | 330.27M | 332.00M | 325.34M |
| SG&A Expenses | 113.39M | 112.68M | 111.53M | 112.86M | 115.77M |
| Depreciation & Amortization | 26.28M | 26.15M | 26.04M | 25.94M | 25.90M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 243.11M | 215.16M | 189.91M | 183.59M | 181.48M |
| Operating Income | 168.22M | 173.36M | 180.32M | 186.25M | 177.23M |
| Income Before Tax | 326.86M | 156.52M | 65.55M | -46.33M | 37.39M |
| Income Tax Expenses | 55.70M | 29.18M | 26.90M | 13.40M | 14.00M |
| Earnings from Continuing Operations | 271.17 | 127.34 | 38.65 | -59.72 | 23.39 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 271.17M | 127.34M | 38.65M | -59.72M | 23.39M |
| EBIT | 168.22M | 173.36M | 180.32M | 186.25M | 177.23M |
| EBITDA | 194.63M | 199.64M | 206.48M | 212.30M | 203.26M |
| EPS Basic | 3.77 | 1.90 | 0.61 | -0.95 | 0.37 |
| Normalized Basic EPS | 1.59 | 1.70 | 1.78 | 1.81 | 1.71 |
| EPS Diluted | 3.05 | 1.39 | 0.33 | -1.00 | 0.21 |
| Normalized Diluted EPS | 1.36 | 1.39 | 1.54 | 1.69 | 1.51 |
| Average Basic Shares Outstanding | 269.43M | 257.26M | 250.77M | 250.43M | 250.91M |
| Average Diluted Shares Outstanding | 317.39M | 316.33M | 294.31M | 272.39M | 294.21M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |